Emergency FDA authorization of COVID-19 saliva test could be game-changer

ESPN: The U.S. Food and Drug Administration issued an emergency authorization on Saturday allowing public use of a saliva-based test for the coronavirus developed at Yale University and funded by the NBA and the National Basketball Players Association.

The test, known as SalivaDirect, is designed for widespread public screening. The cost per sample could be as low as about $4, though the cost to consumers will likely be higher than that — perhaps around $15 or $20 in some cases, according to expert sources.

FDA allowing saliva-based test funded by NBA

The U.S. Food and Drug Administration issued an emergency authorization on Saturday allowing public use of a saliva-based test for the coronavirus developed at Yale University and funded by the NBA and the National Basketball Players Association.

ESPN.com

Author
Recent Posts

News Feed

The SuperWest Sports News Feed does not link to stories behind a paywall. News is added periodically throughout the day, so check back regularly.